Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 58,910 $ 1,716
Prepaid expenses 1,485 120
Other current assets 19 7
Total current assets 60,414 1,843
Property and equipment, net 1,952 334
In-process research and development 26,623 0
Other assets 1,402 921
Total assets 90,391 3,098
Current liabilities:    
Accounts payable 2,517 934
Accrued liabilities 2,690 1,210
Current portion of long-term debt 2,400 2,400
Related party debt (Note 8) 0 7,315
Deferred revenue 2,765 1,870
Other current liabilities 70 36
Total current liabilities 10,442 13,765
Warrant liabilities 954 49
Long-term debt, net of current portion 1,078 3,165
Other liabilities 628 53
Total liabilities 13,102 17,032
Commitments and contingencies (Note 10)
Redeemable convertible preferred stock 0 25,871
Stockholders’ equity (deficit):    
Common stock, $0.001 par value: Authorized: 150,000,000 shares at December 31, 2017 and 2016; Issued and outstanding: 26,898,330 and 303,303 shares at December 31, 2017 and 2016, respectively 27 0
Additional paid-in capital 141,733 568
Accumulated other comprehensive loss 0 0
Accumulated deficit (64,471) (40,373)
Total stockholders’ equity (deficit) 77,289 (39,805)
Total liabilities and stockholders’ equity (deficit) $ 90,391 $ 3,098